BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 15853442)

  • 1. Chemotherapy-induced ovarian failure: manifestations and management.
    Molina JR; Barton DL; Loprinzi CL
    Drug Saf; 2005; 28(5):401-16. PubMed ID: 15853442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility.
    Schover LR
    J Clin Oncol; 2008 Feb; 26(5):753-8. PubMed ID: 18258983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy and fertility.
    Blumenfeld Z
    Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):379-90. PubMed ID: 22281514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing ovarian failure associated with chemotherapy.
    Cui W; Stern C; Hickey M; Goldblatt F; Anazodo A; Stevenson WS; Phillips KA
    Med J Aust; 2018 Nov; 209(9):412-416. PubMed ID: 30376664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced female infertility and protective action of gonadotropin-releasing hormone analogues.
    Imai A; Furui T
    J Obstet Gynaecol; 2007 Jan; 27(1):20-4. PubMed ID: 17365452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility after breast cancer treatment.
    Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.
    Knobf MT
    Oncologist; 2006 Feb; 11(2):96-110. PubMed ID: 16476831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of gonadal damage during cytotoxic therapy.
    Blumenfeld Z; Haim N
    Ann Med; 1997 Jun; 29(3):199-206. PubMed ID: 9240625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: A systematic review.
    Overbeek A; van den Berg MH; van Leeuwen FE; Kaspers GJ; Lambalk CB; van Dulmen-den Broeder E
    Cancer Treat Rev; 2017 Feb; 53():10-24. PubMed ID: 28056411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of postmenopausal symptoms in breast cancer survivors.
    Bruno D; Feeney KJ
    Semin Oncol; 2006 Dec; 33(6):696-707. PubMed ID: 17145350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian failure following cytotoxic therapy.
    Beard ME; Conder JL; Clark VA
    N Z Med J; 1984 Nov; 97(767):759-62. PubMed ID: 6436759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature ovarian failure: clinical presentation and treatment.
    Kovanci E; Schutt AK
    Obstet Gynecol Clin North Am; 2015 Mar; 42(1):153-61. PubMed ID: 25681846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Premature ovarian failure after chemotherapy for breast cancer].
    Mathelin C; Brettes JP; Diemunsch P
    Bull Cancer; 2008 Apr; 95(4):403-12. PubMed ID: 18495569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females.
    Potolog-Nahari C; Fishman A; Cohen I
    Gynecol Endocrinol; 2007 May; 23(5):290-4. PubMed ID: 17558688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian function following radiation and chemotherapy for cancer.
    Lo Presti A; Ruvolo G; Gancitano RA; Cittadini E
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113 Suppl 1():S33-40. PubMed ID: 15041128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects.
    Reichman BS; Green KB
    J Natl Cancer Inst Monogr; 1994; (16):125-9. PubMed ID: 7999454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
    Del Mastro L; Boni L; Michelotti A; Gamucci T; Olmeo N; Gori S; Giordano M; Garrone O; Pronzato P; Bighin C; Levaggi A; Giraudi S; Cresti N; Magnolfi E; Scotto T; Vecchio C; Venturini M
    JAMA; 2011 Jul; 306(3):269-76. PubMed ID: 21771987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced damage to ovary: mechanisms and clinical impact.
    Bedoschi G; Navarro PA; Oktay K
    Future Oncol; 2016 Oct; 12(20):2333-44. PubMed ID: 27402553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian and Uterine Functions in Female Survivors of Childhood Cancers.
    Oktem O; Kim SS; Selek U; Schatmann G; Urman B
    Oncologist; 2018 Feb; 23(2):214-224. PubMed ID: 29158370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.
    Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Rea S
    Cancer; 2006 Feb; 106(3):514-23. PubMed ID: 16388519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.